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Objective: To evaluate subjective sleep quality and its relationship to fatigue in older adults with oste-
oarthritis (OA).
Method: In a community cohort with hip/knee OA, subjective sleep quality was assessed using the
Pittsburgh Sleep Quality Index (PSQI) and fatigue was measured by the Proﬁle of Mood States e Fatigue
subscale (POMS-F). Correlates of sleep quality and fatigue were determined by standardized interviews
including socio-demographics, OA severity (Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC) summary score), comorbidity, depression (Center for Epidemiologic Studies Depression
Scale, CES-D), stressful life events, daytime napping, symptoms of restless legs syndrome (RLS) and prior
sleep disorder diagnoses. Logistic regression examined correlates of poor sleep (PSQI score> 5). Linear
regression evaluated the relationship between poor sleep and fatigue, and the effect of napping on this
relationship.
Results: In 613 respondents, mean age was 78 years, 78% were female, 11% had concomitant ﬁbromyalgia,
and 26% had 3þ comorbid conditions. Responses indicated moderate OA severity. Seventy percent reported
poor sleep; 25% met criteria for RLS and 6.5% reported a diagnosed sleep disorder. Independent correlates
of poor sleep were: greater arthritis severity (adjusted odds ratio (OR) per unit increase in WOMAC
score¼ 1.03, P<0.0001), 3þ comorbid conditions (adjusted OR¼ 1.88; P¼ 0.03), depressed mood (adjusted
OR per unit increase in CES-D score¼ 1.09, P< 0.0001), and RLS (adjusted OR¼ 1.87; P¼ 0.02). Controlling
for previously reported fatigue correlates, poor sleep was signiﬁcantly associated with greater fatigue
(parameter estimate¼ 1.63, P¼ 0.0003) and napping did not moderate this relationship (P¼ 0.55 for the
interaction between napping and poor sleep).
Conclusions: Among older people with OA, poor sleep is highly prevalent and signiﬁcantly linked with
fatigue. Identifying the nature of sleep disturbances in OA is important as treatment of sleep disturbances
may reduce OA-related fatigue.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Individuals with osteoarthritis (OA) have identiﬁed fatigue as
a key concern1. In contrast to inﬂammatory forms of arthritis, like
rheumatoid arthritis (RA), OA has traditionally been consideredGillian A. Hawker, Women’s
815, Toronto, Ontario, Canada
. Hawker).
s Research Society International. P‘non-inﬂammatory’; thus, fatigue has not generally been ascribed
to OA or routinely assessed clinically or in research. Few studies
have examined fatigue in older adults with OA. Those that have,
found that similar proportions of patients with RA and OA reported
‘clinically important’ fatigue2e6 and have variably linked OA-re-
lated fatigue with older age7, greater pain and disability2,6,7, worse
health status8 and psychosocial factors, including depression2,7,9,
and stressful interpersonal life events10.
Another important factor contributing to fatigue may be poor
sleep quality, which may be particularly relevant in the OA pop-
ulation. Sleep disturbances, such as insomnia, sleep disorderedublished by Elsevier Ltd. All rights reserved.
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older persons, women, and those who are obese, the same groups
most often affected by OA, and may be exacerbated by medications
used to treat OA pain (e.g., opioid analgesics). Although no study
has evaluated sleep disturbances in older adults with painful OA
using objective measures, including overnight polysomnography,
prior research has shown that self-reported sleep disturbances,
including problems with sleep onset, maintenance and early
morning awakenings, are commonly reported by people with
OA11e13, in women more so than men6,14e18. Despite this, little has
been done to characterize these sleep complaints, and to
examine the extent to which underlying sleep disturbances explain
OA-related fatigue, controlling for other factors6,19,20. Additionally,
we lack information about the role of other personal and health
factors, like stressful life events, comorbidities and daytime
napping, on sleep in OA.
The objectives of this study were to determine, among older
adults living with painful OA: the prevalence and key correlates of
subjective sleep quality; the relationship between self-reported
poor sleep and fatigue, controlling for previously identiﬁed corre-
lates of OA-related fatigue; and the effect of regular daytime
napping on the relationship between sleep quality and fatigue.
Methods
Study population
Participants were part of a longitudinal cohort study of individ-
uals with moderate-to-severe hip or knee OA. Details of cohort
recruitment have been published previously21e23. In brief, partici-
pants were recruited between 1995 and 1997 through a screening
survey of 100% of the population 55þ years of age residing in two
regions of Ontario, Canada, one rural and one urban. From 28,451
respondents, individuals were selected for cohort inclusion if they:
(1) reported difﬁculty in the last 3 months with each of stair
climbing, rising from a chair, standing and walking and (2) swelling,
pain or stiffness in any joint lasting at least 6 weeks; and (3) indi-
cated on a diagram that a hip or knee had been ‘troublesome’.
Ninety-six percent of those who met screening criteria had hip or
knee arthritis on examination. Based on these criteria, a cohort of
2,411 individuals was established. Follow-up has been conducted by
standardized telephone interview annually since inception; data for
the present study are based on Year 2007 interviews, which, for the
ﬁrst time, incorporated a detailed assessment of subjective sleep
quality and fatigue.
Assessments
Participants provided information about their age, sex, marital
status, education, annual household income, living circumstances
(independent alone, independent with others, nursing home/resi-
dential care facility), body mass index (BMI), severity of hip/knee
symptoms and disability (Western Ontario McMaster Universities
OA Index [WOMAC] pain and function subscales and summary
score)24, and arthritis treatments ever/currently used. Comorbid-
ities were identiﬁed using a list of 18 health conditions and
diseases, including ﬁbromyalgia syndrome (FMS), for which
participants had received treatment or had seen a physician in the
past year. Depressive symptoms were assessed by the Center for
Epidemiologic Studies Depression Scale (CES-D)25. Life events were
assessed by a modiﬁed Life Experiences Survey (LES)9,26, which
measures the number of positive and negative life events in the
past year. Items irrelevant to an older population were omitted
(e.g., became pregnant) and one item was added (death of a pet).
Items pertaining to major changes in sleeping habits were excludedas they may relate to sleep disturbance and thus may confound the
relationships under examination.
Fatiguewas measured using the Proﬁle of Mood Statese Fatigue
scale (POMS-F)27. The POMS-F evaluates overall fatigue; respon-
dents rate the extent to which they have felt worn out, fatigued,
exhausted, sluggish, and weary in the past month (0¼ not at all;
4¼ extremely).
Perceived sleep quality was assessed using the Pittsburgh Sleep
Quality Index (PSQI)28,29. The PSQI assesses seven sleep quality
domains: sleep duration and latency, habitual sleep efﬁciency, sleep
disturbances, use of sleep medication, daytime dysfunction and
subjective sleep quality over the prior month. Each domain is scored
from 0e3; domains are summed to yield a global score from 0e21,
where higher scores indicate worse sleep quality. The PSQI has been
shown to be reliable and valid28,29 with stable scores over time30;
a global score of >5 is associated with 98.7% sensitivity and 84.4%
speciﬁcity to discriminate individuals with insomnia from controls31.
We also included three questions recommended for diagnosis of RLS
in epidemiologic studies by the International Restless Legs
Syndrome Study Group32. An afﬁrmative response to each of: ‘Do
you have unpleasant sensations in your legs combined with an urge
or need to move your legs?’, ‘Do these feelings or symptoms occur
mainly or only at rest and do they improve with movement?’ and
‘Are these feelings or symptoms worse in the evening or night than
in the morning?’ is associated with 87.5% sensitivity and 96% spec-
iﬁcity for RLS compared to diagnostic interviews32. Average number
of days/week with naps and average minimum duration of naps
were also assessed. Finally, participants were asked if they had ever
received a physician diagnosis of a sleep disorder, and if so, whether
they were currently being treated for this condition.
Statistical analysis
All analyses were performed using the Statistical Analysis System
(SAS) Version 9.1 (SAS Institute, Cary, NC). Statistical signiﬁcancewas
considered at a two-tailed level of 0.05. Descriptive statistics were
performed on all data. Logistic regression was used to determine the
correlates of ‘poor sleep’, deﬁned as a PSQI global score>5. Variables
of interestwere: socio-demographics (age, sex, income); arthritispain
and disability (WOMAC scores); obesity (BMI> 30 kg/m2); comor-
bidity (self-reported diagnosis of FMS; number of other comorbid
conditions e 0e1, 2, 3þ); depressed mood (CES-D scores), positive
and negative life events, RLS, and napping (<4 vs 4þ times/week). As
the frequency of life events was non-normally distributed, negative
and positive life events were dichotomized at themedian, thus as2
vs >2 and 0 vs 1þ, respectively. Each correlate was examined bivari-
ately; those associated with poor sleep at a P-value 0.10 were then
evaluated simultaneously in multivariable regression analysis to
determine independent correlates. As WOMAC subscale and
summary scores were highly correlated, subsequent multivariable
analysis used theWOMAC summary score as the measure of arthritis
severity. Due to the known relationship between sleep and FMS, we
conducted a sensitivity analysis in which we excluded individuals
with co-occurring FMS.
T-tests were used to compare mean values for self-reported
fatigue for those with vs without ‘poor sleep’. The independent
relationship of ‘poor sleep’ to self-reported fatigue was then eval-
uated using linear regression, controlling for the following previ-
ously identiﬁed correlates of fatigue: age, sex, arthritis severity
(WOMAC summary scores), number of comorbid conditions, FMS,
depressed mood, and stressful life events. We then tested for an
interaction between poor sleep and regular daytime napping
(deﬁned as napping 4 times/week vs less often) to examine
whether regular napping moderated the effect of poor sleep on
fatigue. We hypothesized that the effect of poor sleep on fatigue
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a restorative effect.
Ethics
The procedures followed were in accordance with the ethical
standards of the responsible committee on human experimentation
(Women’s College Hospital Research Ethics Board, Toronto, Canada)
and with the Helsinki Declaration of 1975, as revised in 2000. All
subjects gave informed consent to participate in this research.
Results
Sample characteristics
Of the original cohort of 2,411, 805 were deceased, 470 were
ineligible or unable to participate, 370 had refused further follow-up
and 93 were lost to follow-up, leaving 673 individuals. These indi-
viduals were approached for participation in 2007. Of these, eight
had died, one was ineligible, 24 were unable to participate due to
illness, 29 could not be located and 14 refused. As well, 16 new
participants were added to the cohort; these individuals were
acquaintances of the original cohort participants, met eligibility
criteria and had similar demographic characteristics as the original
cohort (data not shown), and requested participation in the study,
providing a sample of 613 for this analysis. Compared with the
original cohort, the 613 participants were younger, more likely to be
female and livingwith others, and had higher income and education.
Participant characteristics are shown inTable I.Mean agewas 77.8
years (range 59e98) three-quarters were female and 37.7% had anTable I
Characteristics of respondents (n¼ 613*)
Characteristic Total cohort (n¼ 613)
Age (years) e mean (SD) 77.82 (6.95)
Female e n (%) 476 (77.7)
Level of education e n (%)
 High school 463 (75.53%)
Post-secondary 150 (24.47%)
Annual household income e n (%)
$20,000 221/586 (37.71%)
$21,000e$40,000 306 (52.22%)
>$40,000 59 (10.07%)
Living circumstances e n (%)
Living alone, independently 230/591 (38.92%)
Living with others, independently 343 (58.04%)
Institution (e.g., long term care, etc.) 18 (3.05%)
BMI (kg/m2) e mean (SD) 28.61 (5.81)
Obese (BMI> 30 kg/m2) e n (%) 188 (33.16%)
OA Severity e mean (SD)
WOMAC pain scale/20 9.01 (3.93)
WOMAC physical function scale/68 34.53 (14.18)
WOMAC summary score/96 46.09 (19.30)
Undergone total hip or knee joint replacement 237 (38.66%)
Comorbid medical conditions e n (%)
Number of comorbidities
None 77/590 (13.05%)
1e2 359 (60.84%)
3þ 154 (26.10%)
Physician-diagnosed FMS 66 (10.77%)
LES e n (%)
Positive life events: 1 event 72 (11.75%)
Negative life events: >2 events 262 (42.74%)
Depressed mood (CES-D score)/20 e mean (SD) 11.35 (8.64)
Score 16 indicating possible depression e n (%) 141 (23.0%)
* The denominator is provided when less than 613.annual income$20,000.MeanWOMAC scores indicatedmoderate-
to-severe OA; 39% had undergone hip or knee joint replacement
surgery. Twenty-six percent reported 3þ comorbid conditions, 10.8%
reported physician-diagnosed FMS (65/66were female), and 23%had
CES-D scores 16 indicating possible clinical depression. Few
participants reported 1þ positive life events in the prior year (11.7%),
whereas 42.7% reported > two negative life events.
Self-reported sleep quality, fatigue, sleep disorders and napping
Participants’ mean global PSQI score was 8.0/21 (range 1e19);
70% had a global score >5 indicating poor sleep quality (Table II).
PSQI subscale scores were highest for sleep latency (difﬁculty
falling asleep) followed by sleep disturbances (interrupted sleep).
Participants’ mean fatigue score was 11.6/20 (Standard deviation
(SD) 5.8). One-quarter of participants met criteria for RLS and
159 (25.9%) reported currently using medications for sleep. Only
39/596 (6.5%) reported a physician-diagnosed sleep disorder; of
these, 26 (66.7%) were receiving treatment. Most participants
napped at least once/week (433/510, 84.9%); 218 (42.7%) napped
4þ times weekly.
Correlates of poor sleep quality
In unadjusted analyses, the odds of reporting poor sleep was
greater among those who were female, had lower income, greater
arthritis pain or disability, greater comorbidity, higher BMI, a diag-
nosis of FMS, greater scores for depressed mood and negative
life events, RLS symptoms, and reported napping 4þ times/week
(Table III). In multivariable analyses, independent correlates of poor
sleep were: greater arthritis severity (WOMAC summary score;
adjusted odds ratio (OR)¼ 1.03, P< 0.0001), having 3þ comorbid
conditions (adjusted OR¼ 1.88; P¼ 0.03), depressed mood (CES-D
score; adjusted OR¼ 1.09, P< 0.0001), and symptoms of RLS
(adjusted OR¼ 1.87; P¼ 0.02) (Table III). Adjusting for use of sleep
medications, or excluding individuals with concomitant FMS or
those who were taking sleep medications, did not substantively
alter our results (data not shown).Table II
Self-reported sleep quality, fatigue, sleep disorders and napping in 613* cohort
participants
Characteristic Total cohort (n¼ 613)
Self-reported fatigue (POMS-F)/20 11.59 (5.80)
Met criteria for RLS 152 (24.80%)
Using medications for sleep 159 (25.98%)
Napping
No 77/510 (15.10%)
Yes, once a week on average 40 (7.84%)
Yes, 2e3 times a week on average 175 (34.31%)
Yes, 4þ times a week on average 218 (42.75%)
Self-reported diagnosis of a sleep disorder 39/596 (6.54%)
Currently receiving treatment 26/39 (66.67%)
PSQI
Global score,/21, Mean (SD), median 7.95 (3.94), 8
Poor sleep (score >5) 429 (69.98%)
Sleep latency,/3, Mean (SD), median 1.71 (0.94), 2
Sleep duration,/3, Mean (SD), median 0.84 (0.80), 1
Sleep duration >7 h 222 (36.22%)
Habitual sleep efﬁciency,/3, Mean (SD), median 1.17 (1.13), 1
Sleep efﬁciency >85%y 225 (36.70%)
Sleep disturbances,/3, Mean (SD), median 1.42 (0.50), 1
Sleep medications,/3, Mean (SD), median 0.72 (1.20), 0
Daytime dysfunction,/3, Mean (SD), median 0.90 (0.82), 1
Subjective sleep quality,/3, Mean (SD), median 1.19 (0.84), 1
* Denominators are provided when less than 613.
y Sleep efﬁciency refers to the proportion of time spent in bed that is spent asleep.
Table III
Correlates of poor global sleep quality as determined by multivariable logistic regression (n¼ 577)
Independent variable Dependent variable¼ poor vs normal sleep quality (Pittsburgh Global Sleep Quality Score >5 vs 5)
Unadjusted OR
(95 % Conﬁdence interval)
P value Adjusted OR
(95% Conﬁdence interval)
P value
Age (per year) 1.03 (1.00e1.05) 0.07 0.99 (0.96e1.03) NS
Sex (female) 2.27 (1.53e3.37) <0.0001 1.59 (0.94e2.68) NS
Annual household income
$20,000 (reference) e e
$21,000e$40,000 0.53 (0.36e0.79) 0.002 0.98 (0.60e1.58) NS
>$40,000 0.245 (0.13e0.45) <0.0001 0.94 (0.43e2.09) NS
WOMAC pain score (per unit increase) 1.25 (1.19e1.32) <0.0001* e e
WOMAC physical function score (per unit increase) 1.07 (1.05e1.09) <0.0001* e e
WOMAC summary score (per unit increase) 1.05 (1.04e1.06) <0.0001 1.03 (1.01e1.04) <0.0001
Comorbidity
<2 conditions (reference) e e
Two comorbid conditions 1.70 (1.14e2.54) 0.01 1.33 (0.82e2.14) NS
3þ comorbid conditions 3.14 (1.92e5.12) <0.0001 1.88 (1.06e3.33) 0.03
Obese (yes) 1.28 (0.87e1.90) NS e e
BMI (per unit increase) 1.03 (1.00e1.07) 0.04 1.02 (0.98e1.06) NS
FMS diagnosis (yes) 3.38 (1.58e7.23) 0.002 1.83 (0.79e4.27) NS
CES-D Depression score (per unit increase) 1.15 (1.11e1.19) <0.0001 1.09 (1.05e1.13) <0.0001
Positive life events (1 event) 0.67 (0.40e1.12) NS e e
Negative life events (>2 events) 2.63 (1.80e3.84) <0.0001 1.38 (0.88e2.16) NS
RLS (yes) 1.98 (1.27e3.09) 0.003 1.87 (1.13e3.12) 0.02
Napping (4 times per week) 2.40 (1.61e3.57) <0.0001 1.35 (0.83e2.19) NS
C Statistic for the ﬁnal model¼ 0.80; Hosmer and Lemeshow Goodness of Fit test Chi Square 4.11, df¼ 8, P¼ 0.85.
NS: not statistically signiﬁcant at two-tailed P-value 0.10.
* WOMAC pain and disability sub-scores highly correlated with summary score; summary score used in multivariable analysis.
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Mean fatigue scores were signiﬁcantly higher among thosewith vs
without ‘poor sleep’ (13.1 vs 8.1, P< 0.0001). Adjusting for age, sex,
arthritis severity, depressedmood, concomitant FMS, and comorbidity,
poor sleep was independently associated with greater fatigueTable IV
Relationship between perceived ‘Poor Sleep’ and Self-Reported Fatigue: results of
linear regression analyses (n¼ 581)
Independent variable Dependent variable¼ POMS-Fatigue Score
Adjusted
Parameter
Estimate*
(P value)
R2 Parameter estimate
further adjusted
for napping
(P value)
R2
Age (per year) 0.04 (NS)y 0.44 0.03 (NS) 0.455
Sex (female) 1.87 (<0.0001) 2.02 (<0.0001)
WOMAC summary score
(per unit increase)
0.10 (<0.0001) 0.09 (<0.0001)
Comorbidity
<2 conditions
(reference)
Reference Reference
2 comorbid
conditions
0.02 (NS) 0.15 (NS)
3þ comorbid
conditions
0.77 (NS) 0.56 (NS)
FMS diagnosis (yes) 1.83 (0.003) 1.91 (0.0015)
CES-D Depression score
(per unit increase)
0.14 (<0.0001) 0.13 (<0.0001)
Negative life events
(>2 events)
0.72 (NS) 0.74 (NS)
Napping (4 times
per week)
e 1.48 (0.0003)
Poor sleep (PSQI global
score >5 vs 5)
1.63 (0.0003) 1.57 (0.0005)
* Adjusted for all other variables. The cross-product interaction term between
poor sleep and regular daytime napping was not signiﬁcant (P¼ 0.55), thus for
simplicity not included in the model.
y NS¼ not statistically signiﬁcant (P > 0.05).(parameter estimate 1.63, SE 0.45, P¼ 0.0003) (Table IV). Further
adjustment for regulardaytimenapping showed thatnappingwas also
signiﬁcantly and independently associated with greater fatigue
(adjustedparameterestimate1.48,P¼ 0.0003) (Table IV).However,we
did not ﬁnd that regular nappingmoderated the relationship between
poor sleep and fatigue (P value for the interaction between poor sleep
and napping¼ 0.55, adjusted for all other variables).Discussion
This study is the ﬁrst, to our knowledge, to comprehensively
evaluate the multidimensionality of sleep quality and its indepen-
dent contribution to fatigue among older adults with painful OA.
Our study has documented a high prevalence of poor sleep quality
and has shown that, controlling for a number of other factors,
including arthritis severity, FMS, depressed mood, stressful life
events and daytime napping, poor sleep and self-reported fatigue
are independently and signiﬁcantly linked in this population. Using
a published cut-point on the PSQI that has been used by others31,
we found that two-thirds of older people living with painful,
disabling hip/knee OA had ‘poor sleep’. This estimate is consistent
with the few other studies that have evaluated self-reported sleep
quality in OA. Among participants of the Johnston County Osteo-
arthritis Project12, 76.4% of 759 subjects with hip/knee OA reported
any sleep problem, while in a large community sample of 429
adults aged 65þ years with knee pain, 31% reported problems with
sleep onset, 81% with sleep maintenance and 51% with early
morning awakenings at least weekly33. A third study reported
a lower prevalence of sleep problems (insomnia in 25% and unre-
freshing sleep in 11%) in a large nationally representative sample of
Canadianswho self-reported ‘arthritis’ or ‘rheumatism’34. However,
this sample included a broad age range (18 and older) and did not
distinguish between types of arthritis or symptom severity. Our
study also conﬁrmed previously reported cross-sectional relation-
ships between poor sleep and both arthritis pain and depressed
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tionships with both greater comorbidity and symptoms of RLS.
Fatigue has been documented as a common complaint in many
medical conditions6,38,39, including more recently OA1,2,6e10,40,41.
In addition to its link with poor sleep quality, our study documented
signiﬁcant independent relationships between greater OA-related
fatigue and female sex, greater OA pain and disability, concomitant
FMS, and depressedmood. Controlling for these factors, we found no
independent effect of older age or greater comorbidity.
Previous research has shown a relationship between stressful
life events and both fatigue10 and depressedmood in OA9. However,
no study has previously examined the impact of stressful life events
on sleep in this population. Few of our participants had experi-
enced positive life events over the prior year, whereas negative life
events were relatively common and, as expected, associated with
both greater fatigue and poor sleep. However, these relationships
became non-signiﬁcant after controlling for depressed mood,
suggesting that mood mediates the effect of stressful life events on
both fatigue and sleep. These ﬁndings underscore the importance
of contextual factors on the complex relationships among mood,
sleep and fatigue in older peoples’ lives.
RLS has been estimated to affect 10e35% of individuals aged
65þ years, with womenmore often affected thanmen37. Consistent
with these estimates, and using a recommended and validated
algorithm to diagnose RLS in epidemiologic studies32, 24.8% of our
study participants were found to have RLS. However, compared
with diagnostic interview, the sensitivity of this approach to
identify RLS has been shown to be 87.5%; thus, wemay have under-
estimated the true prevalence in study participants. Among
specialty sleep clinic patients, it has been shown that sleep quality
is related not only to the presence of RLS, but also to the severity of
the RLS symptoms37,42. Despite the high prevalence of RLS and
associated poor sleep, and the availability of safe and effective
therapies to treat most common sleep disturbances in older indi-
viduals43e45, few participants had been diagnosed with a sleep
disorder or were receiving treatment, suggesting a health care gap.
As noted in other studies of older adults, daytime napping was
commonly reported46e48. Individuals who reported napping had
worse self-reported sleep quality and higher levels of fatigue than
those who napped less frequently. This suggests that napping may
be used to combat fatigue related to poor sleep and/or that napping
is simply a manifestation of high levels of fatigue. Furthermore, we
found no evidence to suggest that regular napping had a restorative
effect among those with poor sleep. It has been suggested that
daytime napping may adversely impact nighttime sleep49,50.
However, after we controlled for other factors, we found no cross-
sectional independent relationship between regular daytime
napping and self-reported sleep quality. Picarsic et al found that
54% of 414 older adults napped at least once weekly; napping was
associated with greater fatigue and male sex, but not with sleep
efﬁciency or sleep latency46. Others have also reported the lack of
an association between napping and sleep parameters37,46, sug-
gesting that while napping is common it doesn’t appear to
adversely affect nighttime sleep. One explanation may be that the
quality of daytime sleep while napping may also be poor, and
therefore non-restorative, due to the presence of an intrinsic sleep
disturbance such as obstructive sleep apnea. Or, it may be that the
effect of napping on sleep depends on the timing and duration of
the naps. For example, napping late in the day has been shown to
have a particularly negative impact on nighttime slowwave sleep51.
Prospective studies, with attention to the timing, duration and
frequency of naps, are needed to further elucidate the negative/
positive impact of napping on sleep and fatigue among older adults.
There is a known association between obesity and obstructive
sleep apnea52. Two studies12,33 previously examined the relationshipbetween BMI and sleep quality in OA and found no association. Our
study similarly found no relationship between poor sleep, measured
using the global PSQI score, and BMI or obesity after controlling for
arthritis severity. However, the use of a global sleep score may
obscure important patterns of subjective sleep problems that may
provide clues to the presence of underlying sleep disturbances. For
example, sleep disordered breathing would be expected to particu-
larly impact sleep maintenance while RLS might prolong sleep
initiation. Alternatively, the predominantly female study population
(inwhom the relationship between BMI and OSA has been shown to
be less strong53e55) and/or a high prevalence of mild sleep apnea
may explain this ﬁnding. Further research is warranted to evaluate
the underlying sleep disturbances in OA using objective measures,
such as polysomnography.
Strengths of our study were our large community-based
cohort of older individuals with symptomatic OA unselected for
sleep problems or fatigue, and the comprehensive assessment of
sleep quality and fatigue controlling for key covariates, including
stressful life events, concomitant FMS, and napping. However,
there are also some potential weaknesses. First, the complex
causal relationships among the variables considered cannot be
fully appreciated in a cross-sectional study. Whether poor sleep
leads to fatigue can only be elucidated through longitudinal
research. Based on our ﬁndings, future longitudinal studies
should incorporate the role of contextual factors, such as stressful
life events, in triggering sleep problems, and take into consider-
ation the impact of sleep medications on subjective sleep quality
and on OA pain and disability. Second, our assessment of sleep
quality was based on self-report. It is unclear to what extent self-
reported sleep disturbances accurately predict ﬁndings on
objective measures of sleep, such as overnight polysomnography.
Research is needed to elucidate the nature of underlying sleep
disturbances in OA using such measures, as well as their rela-
tionship with measures of subjective sleep quality. Third, the
occurrence of napping was also based on self-report, which may
underestimate both the frequency and duration of naps, poten-
tially biasing against ﬁnding an association, positive or negative,
between napping and sleep. Fourth, we did not evaluate the
impact of physical activity, alcohol or caffeine consumption on
self-reported sleep quality. Finally, we did not exclude individuals
with concomitant FMS; FMS is known to be associated with
fatigue and poor sleep56. However, in a sensitivity analysis
in which we excluded these individuals, our results were
unchanged.
In conclusion, in a large community cohort with symptomatic
hip/knee OA self-reported poor sleep was highly prevalent and
independently and signiﬁcantly linked to self-reported fatigue.
Despite this, few participants had been diagnosed, or treated, for an
underlying sleep disturbance or sleep disorder. Greater attention to
the determinants and consequences of poor sleep in people living
with painful OA is warranted, particularly among vulnerable
subgroups such as women and those with severe OA, so that
underlying causes can be identiﬁed and appropriate interventions
provided. In particular, studies are needed to characterize the sleep
disturbances and disorders underlying these sleep complaints
using physiologic measures, including overnight polysomnography.
Identifying the nature of sleep disturbances in OA is extremely
important as most sleep disturbances are directly amenable to
effective therapies57. Furthermore, should longitudinal studies
identify a causal relationship between sleep disturbances and
OA-related fatigue, this will lay the foundation for clinical trials of
interventions directed at ameliorating identiﬁed sleep distur-
bances, e.g., use of medications for the treatment of RLS and peri-
odic limb movements during sleep, as a strategy for relieving
OA-related fatigue.
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